Prognosis and Therapeutic Biomarkers for Glioblastoma Patients

Stopped early

Conditions studied: Glioblastoma

In brief

The purpose of this study is to investigate if the potential biomarkers identified could be used for facilitating the diagnosis and prognosis of patients with glioblastoma (GBM).

Key facts

Study ID

NCT03403803

Run by

Baylor Research Institute

People needed

10

Starts

2017-09-01

Expected to finish

2019-03-25

Last updated by the study team

2019-03-27

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 22 years old
• Control Group (only patients evaluated for neurological disorders whose evaluation require a lumbar puncture)
• Non-Control Group - Diagnosed with GBM (Glioblastoma)

You may not qualify if…

• Pregnancy
• Infectious Disease to include cold, flu, HIV, etc.
• Blood Disorder (example:low platelets, anemia, thrombosis)
• Vascular Malformations

Where it is running

• Baylor Scott and White Medical Center — Temple, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.